Stocks and Investing
Stocks and Investing
Mon, March 25, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Paul Matteis Reiterated (anro) at Strong Buy and Held Target at $32 on, Mar 25th, 2024
Paul Matteis of Stifel, Reiterated "Alto Neuroscience, Inc." (ANRO) at Strong Buy and Held Target at $32 on, Mar 25th, 2024.
Paul has made no other calls on ANRO in the last 4 months.
There are 2 other peers that have a rating on ANRO. Out of the 2 peers that are also analyzing ANRO, 0 agree with Paul's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Paul
- Andrew Tsai of "Jefferies" Initiated at Strong Buy and Held Target at $33 on, Tuesday, February 27th, 2024
- Brian Skorney of "Baird" Initiated at Buy and Held Target at $32 on, Tuesday, February 27th, 2024
Contributing Sources